Related Experiment Videos
[First clinical experiences with the new intracardial electrode "Helifix"]
Schweizerische Medizinische Wochenschrift
|November 5, 1977
Summary
A novel pervenous screw-in electrode shows promise for cardiac pacing, with low rates of dislocation (3.3%) and exit-block (5%) in a patient cohort. These initial results suggest a safe and effective alternative for lead implantation.
Area of Science:
- Cardiovascular device development
- Electrophysiology
- Minimally invasive cardiac procedures
Context:
- Traditional transvenous electrodes carry risks of perforation and lead dislodgement.
- The need for reliable and less invasive pacing lead solutions is ongoing.
- Advancements in screw-in electrode technology aim to improve lead stability and reduce complications.
Purpose:
- To evaluate the safety and efficacy of a newly developed pervenous non-traumatic screw-in electrode.
- To assess the incidence of lead dislocation and threshold increase (exit-block) with the new electrode design.
- To determine the feasibility of using this novel electrode in a clinical setting.
Summary:
- A pervenous non-traumatic screw-in electrode was implanted in 61 patients.
- Two instances (3.3%) of electrode dislocation were observed, requiring repositioning.
- Three cases (5%) presented with an increased pacing threshold (exit-block), also necessitating repositioning.
Impact:
- The new screw-in electrode demonstrates a low complication rate in initial clinical testing.
- Findings support the potential for reduced procedural complications associated with cardiac pacing lead implantation.
- Further research may validate this device as a safe and effective alternative to conventional pacing electrodes.